相关实验视频

Updated: Sep 13, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

一种双价Mpox纳米颗粒疫苗诱导了强大的免疫反应,并提供了长期保护,防止疫苗病毒挑战疫苗病毒

Yanhai Wang^1,2, Hao Sun^1,2, Huixu Zhou³

¹State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People's Republic of China.

Emerging microbes & infections

|July 28, 2025

概括

一种新型的双价病毒 (mpox) 纳米粒子疫苗候选者mi3-AM在小鼠中表现出强大的免疫反应和对致命的骨病毒挑战的长期保护.

科学领域:

疫苗学疫苗学疫苗学
免疫学免疫学免疫学
病毒学病毒学

背景情况:

2022年至2024年的mopox疫情强调了对有效疫苗的需求.
现有的天花疫苗提供交叉保护,但新的疫苗平台正在调查中.
目前正在探索mRNA和蛋白质子单元疫苗用于mpox预防.

研究的目的:

设计和评估一种新型双价病毒 (MPXV) 纳米粒子候选疫苗.
为了评估mi3-AM疫苗的免疫性和保护功效.

主要方法:

使用SpyTag-SpyCatcher系统将MPXV保护性抗原M1R和A35R与mi3纳米粒子结合.
一种双价候选疫苗,mi3-AM,是以mi3-M1R和mi3-A35R的等等分子混合物来制备的.
给小鼠接种了mi3-AM和一个辅助剂,然后接种了疫苗病毒西部储备菌株 (VACV-WR) 的挑战.

主要成果:

该mi3-AM疫苗诱导了强烈的幽默和抗原特异性细胞免疫反应.
接种mi3-AM疫苗的小鼠显示出对致命的VACV-WR挑战的长期保护.
候选疫苗在临床前试验中显示出显著的潜力.

结论:

设计的双价MPXV纳米粒子候选疫苗,mi3-AM,是一个有前途的解决方案,用于orthopoxvirus预防.
这种新型疫苗平台解决了当前mopox疫苗的局限性.
mi3-AM提供了一种潜在的策略,可以弥合全球骨质疏松病毒准备方面的差距.

关键词:

这款A35R就是A35R.M1R 是一个M1R.麻疹病毒病毒的病毒.长期持续的保护保护.纳米颗粒疫苗的使用方法

更多相关视频

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

相关概念视频

Vaccinations

Vaccinations

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Cross-reactivity

Cross-reactivity

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...